SERAVALLE, GINO LUCIANO
SERAVALLE, GINO LUCIANO
Differential effects of renal denervation on skin and muscle sympathetic nerve traffic in resistant and uncontrolled hypertension
2023 Dell'Oro, R; Quarti-Trevano, F; Seravalle, G; Cuspidi, C; Grassi, G
EFFECTS OF CAROTID BARORECEPTOR STIMULATION ON REGIONAL SYMPATHETIC ACTIVITY IN CHRONIC HEART FAILURE
2023 Vanoli, J; Dell'Oro, R; Gronda, E; Quarti-Trevano, F; Seravalle, G; Grassi, G
Relationships between sympathetic markers and heart rate thresholds for cardiovascular risk in chronic heart failure
2023 Grassi, G; Seravalle, G; Vanoli, J; Facchetti, R; Spaziani, D; Mancia, G
ANTIHYPERTENSIVE DRUG TREATMENT IN WHITE-COAT HYPERTENSION: DATA FROM THE PLAQUE HYPERTENSION LIPID-LOWERING ITALIAN STUDY (PHYLLIS)
2022 Quarti-Trevano, F; Seravalle, G; Dell'Oro, R; Facchetti, R; Grassi, G; Mancia, G
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS
2022 Seravalle, G; Biffi, A; Vanoli, J; Quarti-Trevano, F; Dell'Oro, R; Corrao, G; Mancia, G; Grassi, G
DIFFERING EFFECTS OF RENAL DENERVATION ON BLOOD PRESSURE AND SYMPATHETIC NERVE TRAFFIC: A SYSTEMATIC REVIEW AND META-ANALYSIS
2022 Seravalle, G; Biffi, A; Vanoli, J; Quarti-Trevano, F; Dell'Oro, R; Corrao, G; Mancia, G; Grassi, G
Elevated heart rate as sympathetic biomarker in human obesity
2022 Seravalle, G; Facchetti, R; Cappellini, C; Annaloro, A; Gelfi, E; Grassi, G
Heart rate thresholds for cardiovascular risk and sympathetic activation in the metabolic syndrome
2022 Seravalle, G; Vanoli, J; Molisano, C; Merati, V; Grassi, G
Neuroadrenergic activation in obstructive sleep apnoea syndrome: A new selectedmeta-analysis - revisited
2022 Biffi, A; Quarti-Trevano, F; Bonzani, M; Seravalle, G; Corrao, G; Mancia, G; Grassi, G
New-onset aortic dilatation in the population: a quarter-century follow-up
2022 Cuspidi, C; Facchetti, R; Bombelli, M; Seravalle, G; Grassi, G; Mancia, G
Sleep Apnea and Hypertension
2022 Seravalle, G; Grassi, G
WHITE-COAT HYPERTENSION WITHOUT ORGAN DAMAGE: IMPACT OF LONG-TERM MORTALITY, NEW HYPERTENSION AND NEW ORGAN DAMAGE
2022 Seravalle, G; Facchetti, R; Vanoli, J; Dell'Oro, R; Grassi, G; Mancia, G
White-Coat Hypertension Without Organ Damage: Impact on Long-Term Mortality, New Hypertension, and New Organ Damage
2022 Mancia, G; Facchetti, R; Vanoli, J; Dell'Oro, R; Seravalle, G; Grassi, G
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction
2021 Mancia, G; Facchetti, R; Seravalle, G; Cuspidi, C; Corrao, G; Grassi, G
Autonomic cardiovascular alterations as therapeutic targets in chronic kidney disease
2021 Seravalle, G; Quarti-Trevano, F; Vanoli, J; Lovati, C; Grassi, G
Autonomic Cardiovascular Alterations in Chronic Kidney Disease: Effects of Dialysis, Kidney Transplantation, and Renal Denervation
2021 Quarti-Trevano, F; Seravalle, G; Dell'Oro, R; Mancia, G; Grassi, G
Clinical relevance of the sympathetic–vascular interactions in health and disease
2021 Quarti-Trevano, F; Seravalle, G; Grassi, G
Heart rate as a predictor of cardiovascular risk
2021 Seravalle, G; Quarti Trevano, F; Grassi, G
Limited reliability of heart rate as a sympathetic marker in chronic kidney disease
2021 Dell'Oro, R; Quarti-Trevano, F; Seravalle, G; Bertoli, S; Lovati, C; Mancia, G; Grassi, G
Neuroadrenergic activation in obstructive sleep apnea syndrome: a systematic review and meta-analysis
2021 Quarti-Trevano, F; Biffi, A; Bonzani, M; Seravalle, G; Corrao, G; Mancia, G; Grassi, G